Lantus, a new long-acting insulin
June 2000
The FDA just approved Lantus, a new long-acting insulin from Aventis. It's also being considered in Canada.
Lantus is longer acting than NPH or Ultralente...and doesn't produce peak concentrations like other insulins.
Lantus is a synthetic insulin called insulin glargine. It differs from human insulin by 3 amino acids.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive